Vancomycin minimum inhibitory concentrations using different susceptibility methods in Staphylococcus aureus isolates

被引：1
|
作者：
Sousa, Aline G. P. [1 ]
da Costa, Thaina M. [1 ]
Cavalvante, Fernanda S. [1 ]
Chamon, Raiane C. [1 ]
Ferreira, Dennis C. [1 ,4 ]
Nouer, Simone A. [2 ,3 ]
dos Santos, Katia R. N. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Med, BR-21941590 Rio de Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio de Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Fac Med, BR-21941590 Rio de Janeiro, Brazil
[4] Veiga Almeida Univ, Sch Dent, Dept Oral Med, Rio De Janeiro, Brazil
来源：
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2014年 / 8卷 / 04期
关键词：
Bloodstream infections; Staphylococcus aureus; susceptibility methods; vancomycin; TESTING METHODS; INFECTIONS; BACTEREMIA; MICS;
D O I：
10.3855/jidc.4395
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：558 / 560
页数：3
相关论文
共 50 条
  • [1] Accuracy of a vancomycin brain heart infusion screening plate for the screening of Staphylococcus aureus isolates with increased vancomycin minimum inhibitory concentrations
    Navarini, Alessandra
    Martino, Marines D. V.
    Sasagawa, Suzete M.
    Massaia, Irineu F. D.
    Mimica, Marcelo J.
    NEW MICROBIOLOGICA, 2015, 38 (03): : 423 - 426
  • [2] Increased vancomycin minimum inhibitory concentration among Staphylococcus aureus isolates in Malaysia
    Ahmed, Norazah
    Nawi, Salbiah
    Rajasekaran, Ganeswrie
    Maning, Nurahan
    Aziz, Mohamad Nazri
    Husin, Azura
    Rahman, Nor Iza Abdul
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (12) : 1530 - 1532
  • [3] Performance of different commercial methods for determining minimum inhibitory concentrations of glycopeptides and linezolid against blood isolates of Staphylococcus aureus
    Lo Cascio, G.
    Balzaj, A.
    Maccacaro, L.
    Fontana, R.
    Centonze, A. R.
    Sorrentino, A.
    Mazzariol, A.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2013, 1 (03) : 163 - 169
  • [4] Vancomycin Minimum Inhibitory Concentrations and Outcome in Patients With Severe Staphylococcus aureus Infection
    Gould, Ian Malcolm
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (05): : 864 - 864
  • [5] Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
    Mills, Alexandra G.
    Dupper, Amy C.
    Chacko, Kieran I.
    Alburquerque, Bremy
    Nadkarni, Devika
    Caban, Ana Berbel
    Fox, Lindsey
    Gitman, Melissa R.
    Obla, Ajay
    van Bakel, Harm
    Altman, Deena R.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [6] Vancomycin Minimum Inhibitory Concentrations and Outcome in Patients With Severe Staphylococcus aureus Infection Reply
    Holmes, Natasha E.
    Turnidge, John D.
    Johnson, Paul D. R.
    Howden, Benjamin P.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (05): : 865 - 866
  • [7] CREEP OF VANCOMYCIN MINIMUM INHIBITORY CONCENTRATION IN STAPHYLOCOCCUS AUREUS ISOLATES AT THE NATIONAL HOSPITAL OF SRI LANKA
    Pemasiri, C.
    Karunanayake, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : S12 - S12
  • [8] Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for Staphylococcus aureus with Reduced Vancomycin Susceptibility
    Chung, Hae-Sun
    Lee, Miae
    DIAGNOSTICS, 2022, 12 (04)
  • [9] Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA)
    Anitha, T. K.
    Rao, Morubagal Raghavendra
    Shankaregowda, Ranjitha
    Mahale, Rashmi P.
    Sowmya, G. S.
    Chitharagi, Vidyavathi B.
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2019, 13 (03): : 1797 - 1801
  • [10] Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin
    McMullen, Allison R.
    Lainhart, William
    Wallace, Meghan A.
    Shupe, Angela
    Burnham, Carey-Ann D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (12) : 2323 - 2330
12345